Investing.com - Financial Markets Worldwide

Allurion Technologies stock rating reiterated at Buy by TD Cowen

Published 14/08/2025, 16:52
Allurion Technologies stock rating reiterated at Buy by TD Cowen
ALUR
-3.61%

Investing.com - TD Cowen has reiterated its Buy rating on Allurion Technologies (NYSE:ALUR) with a price target of $6.00, maintaining its positive outlook despite a transitional second quarter. According to InvestingPro data, analyst targets range from $2.50 to $16.00, with the stock currently trading at $2.53 after declining over 76% year-to-date.

The medical device company reported second-quarter revenue of $3.4 million, which aligned with preliminary results announced last week.

Sales were negatively impacted by Allurion’s mid-quarter strategic decision to realign its distribution network toward partners with physician networks that prescribe GLP-1 medications.

TD Cowen noted that while this strategic pivot makes sense for Allurion’s long-term positioning, it will cause disruption in the second half of 2025 and has led the company to withdraw its previous guidance.

The research firm identified potential U.S. regulatory approval by mid-2026 as the most significant upcoming value catalyst for Allurion Technologies.

In other recent news, Allurion Technologies reported its second-quarter 2025 earnings, which showed a noticeable decline in revenue compared to the previous year. The company is currently undergoing a strategic shift, which has influenced both its financial performance and market perception. Despite the revenue drop, Allurion remains optimistic, directing its efforts toward innovative solutions in the obesity market. These developments highlight the company’s focus on adapting its business strategies to align with future goals. While the specific figures were not detailed, the earnings call indicated a significant impact on the company’s financials. This strategic pivot has been a central theme in recent discussions about Allurion Technologies. Investors are keenly observing how these changes will influence the company’s long-term performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.